DK4125887T3 - Anvendelse af et thienopyridonderivat til behandling af en autosomal dominant polycystisk nyresygdom (adpkd) - Google Patents
Anvendelse af et thienopyridonderivat til behandling af en autosomal dominant polycystisk nyresygdom (adpkd) Download PDFInfo
- Publication number
- DK4125887T3 DK4125887T3 DK21715913.6T DK21715913T DK4125887T3 DK 4125887 T3 DK4125887 T3 DK 4125887T3 DK 21715913 T DK21715913 T DK 21715913T DK 4125887 T3 DK4125887 T3 DK 4125887T3
- Authority
- DK
- Denmark
- Prior art keywords
- adpkd
- treatment
- kidney disease
- autosomal dominant
- polycystic kidney
- Prior art date
Links
- 208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 title 2
- 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 title 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20167687 | 2020-04-02 | ||
| PCT/EP2021/058792 WO2021198506A1 (en) | 2020-04-02 | 2021-04-02 | Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (adpkd) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4125887T3 true DK4125887T3 (da) | 2024-05-06 |
Family
ID=70165805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21715913.6T DK4125887T3 (da) | 2020-04-02 | 2021-04-02 | Anvendelse af et thienopyridonderivat til behandling af en autosomal dominant polycystisk nyresygdom (adpkd) |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230120204A1 (da) |
| EP (1) | EP4125887B1 (da) |
| JP (1) | JP7366290B2 (da) |
| KR (1) | KR20220163978A (da) |
| CN (1) | CN115361949A (da) |
| AU (1) | AU2021250655A1 (da) |
| BR (1) | BR112022019403A2 (da) |
| CA (1) | CA3171422A1 (da) |
| DK (1) | DK4125887T3 (da) |
| FI (1) | FI4125887T3 (da) |
| IL (1) | IL296843A (da) |
| MX (1) | MX2022012350A (da) |
| PT (1) | PT4125887T (da) |
| WO (1) | WO2021198506A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022011938A (es) | 2020-03-26 | 2023-01-04 | Poxel | Uso de un derivado de tienopiridona en el tratamiento de la adrenoleucodistrofia o adrenomieloneuropatia. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0910439B8 (pt) | 2008-04-11 | 2021-05-25 | Merck Patent Gmbh | derivados de tienopiridona como ativadores da proteína quinase ativada por amp (ampk), seu processo de preparação, e medicamentos |
| EP2679591A1 (en) * | 2012-06-29 | 2014-01-01 | Poxel | Thienopyridone derivatives useful as activators of AMPK |
| WO2017011917A1 (en) | 2015-07-23 | 2017-01-26 | Thrasos Therapeutics Inc. | Methods for treating and preventing polycystic kidney diseases (pkd) using amp-activated protein kinase (ampk) modulators and activators |
| EP3880683B1 (en) * | 2018-11-16 | 2023-11-01 | Poxel | Monohydrate potassium salt of a thienopyridone derivative and its preparation process |
-
2021
- 2021-04-02 EP EP21715913.6A patent/EP4125887B1/en active Active
- 2021-04-02 AU AU2021250655A patent/AU2021250655A1/en active Pending
- 2021-04-02 WO PCT/EP2021/058792 patent/WO2021198506A1/en unknown
- 2021-04-02 JP JP2022560086A patent/JP7366290B2/ja active Active
- 2021-04-02 DK DK21715913.6T patent/DK4125887T3/da active
- 2021-04-02 CN CN202180027012.1A patent/CN115361949A/zh active Pending
- 2021-04-02 US US17/915,123 patent/US20230120204A1/en active Pending
- 2021-04-02 KR KR1020227037021A patent/KR20220163978A/ko unknown
- 2021-04-02 CA CA3171422A patent/CA3171422A1/en active Pending
- 2021-04-02 IL IL296843A patent/IL296843A/en unknown
- 2021-04-02 MX MX2022012350A patent/MX2022012350A/es unknown
- 2021-04-02 FI FIEP21715913.6T patent/FI4125887T3/fi active
- 2021-04-02 PT PT217159136T patent/PT4125887T/pt unknown
- 2021-04-02 BR BR112022019403A patent/BR112022019403A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220163978A (ko) | 2022-12-12 |
| BR112022019403A2 (pt) | 2022-12-06 |
| US20230120204A1 (en) | 2023-04-20 |
| AU2021250655A1 (en) | 2022-10-27 |
| CA3171422A1 (en) | 2021-10-07 |
| FI4125887T3 (fi) | 2024-05-03 |
| PT4125887T (pt) | 2024-05-06 |
| CN115361949A (zh) | 2022-11-18 |
| MX2022012350A (es) | 2022-10-27 |
| WO2021198506A1 (en) | 2021-10-07 |
| EP4125887A1 (en) | 2023-02-08 |
| IL296843A (en) | 2022-11-01 |
| JP7366290B2 (ja) | 2023-10-20 |
| JP2023510039A (ja) | 2023-03-10 |
| EP4125887B1 (en) | 2024-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1708992T3 (da) | Sulfonamidderivater til behandling af sygdomme | |
| DK1755661T3 (da) | Gelsolin til anvendelse til behandling af infektioner | |
| DK1928438T3 (da) | Anvendelse af ibudilast til behandling af stofafhængighed | |
| DK1940786T3 (da) | Biphenylderivater og deres anvendelse ved behandling af hepatitis C | |
| DK1877096T3 (da) | Nyrestensbehandling uden brug af litotripsi | |
| DK3858977T3 (da) | Stamme til forebyggelse og behandling af stofskiftesygdomme, og brugen heraf | |
| CR10414A (es) | Tratamientos de las alergias oculares | |
| DK1354597T3 (da) | Farmaceutisk kombination til behandling af vævsskader forårsaget af en arterieirrigationsdefekt | |
| DK3914310T3 (da) | Blodpumpe | |
| DK4125887T3 (da) | Anvendelse af et thienopyridonderivat til behandling af en autosomal dominant polycystisk nyresygdom (adpkd) | |
| DK3827004T3 (da) | 4-(1,3,4-oxadiazol-2-yl)pyridin-2(1h)-on-derivater som histondeacetylase-6 (hdac6) hæmmere til behandling af f.eks, infektioner | |
| DK4010329T3 (da) | Deutererede forbindelser til anvendelse ved behandling af cancer | |
| JP1729030S (ja) | カメラ | |
| DK3743064T3 (da) | Behandling af proteinuri | |
| DK1979053T3 (da) | Produkt til behandling af hud og slimhinder og tilhørende fremgangsmåde til fremstilling | |
| DK3860598T3 (da) | Vemurafenib og salte heraf til anvendelse til behandling af enterovirusinfektioner | |
| DK1852426T3 (da) | Fremgangsmåde til fremstilling af en optisk aktiv ppar-aktiverende forbindelse og mellemprodukt af samme | |
| DK4081507T3 (da) | Kemiske forbindelser, der er målrettet øjet, og anvendelse deraf i behandlingen af øjensygdomme | |
| JP1750745S (ja) | サングラス | |
| JP1735468S (ja) | サングラス | |
| JP1768872S (ja) | カメラ | |
| JP1766190S (ja) | カメラ | |
| JP1766133S (ja) | カメラ | |
| JP1768873S (ja) | カメラ | |
| JP1769831S (ja) | カメラ |